Cadrenal Therapeutics Inc. Common Stock (CVKD)
Stock · NASDAQ · Health Care
$1.54as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Resistance level
$1.93
Industry
Biotechnology: Pharmaceutical Preparations
About CVKD
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing Tecarfarin, an oral vitamin K antagonist that is in Phase 3 clinical trial designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation, such as patients with left ventric…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 5
- Website
- www.cadrenal.com
Fundamentals
- 1-day range
- $1.8$1.91
- Market cap
- $6.70M
- P/E (trailing)
- —
- P/E (forward)
- -0.57
- EPS (trailing)
- $-4.88
- Dividend yield
- —
- Beta
- —
- Avg. volume
- 70.1K
52-week range
$1.76$14.64
Forecasts
3 analyst ratings
Buy 100%
Hold 0%
Sell 0%
1-year price forecast
High
$17
+1003.9%
Median
$13
+744.2%
Low
$12
+679.2%
Cadrenal Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CVKDCadrenal Therapeutics Inc. Common Stock$1.53▼ 2.24%Market cap $6.70MP/E —$1.76$14.64
- ALZNAlzamend Neuro Inc. Common Stock$1.66▼ 0.30%Market cap $6.42MP/E —$0.84$2.68
- PCSAProcessa Pharmaceuticals Inc. Common Stock$2.07▼ 1.90%Market cap $7.09MP/E —$1.67$14.24
- TRAWTraws Pharma Inc. Common Stock$0.59▲ 0.00%Market cap $7.18MP/E —$0.4301$3.27
- ACXPAcurx Pharmaceuticals Inc. Common Stock$1.45▼ 1.03%Market cap $6.15MP/E —$1.31$8.34
- APUSApimeds Pharmaceuticals US Inc. Common Stock$3.87▼ 1.28%Market cap $7.32MP/E —$3.39$403.1
- HCWBHCW Biologics Inc. Common Stock$3.39▲ 6.94%Market cap $6.06MP/E —$1.5$38.16
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CVKD Cadrenal Therapeutics Inc. Common Stock | $6.70M | — | $1.53 | ▼ 2.24% | $1.76$14.64 |
| ALZN Alzamend Neuro Inc. Common Stock | $6.42M | — | $1.66 | ▼ 0.30% | $0.84$2.68 |
| PCSA Processa Pharmaceuticals Inc. Common Stock | $7.09M | — | $2.07 | ▼ 1.90% | $1.67$14.24 |
| TRAW Traws Pharma Inc. Common Stock | $7.18M | — | $0.59 | ▲ 0.00% | $0.4301$3.27 |
| ACXP Acurx Pharmaceuticals Inc. Common Stock | $6.15M | — | $1.45 | ▼ 1.03% | $1.31$8.34 |
| APUS Apimeds Pharmaceuticals US Inc. Common Stock | $7.32M | — | $3.87 | ▼ 1.28% | $3.39$403.1 |
| HCWB HCW Biologics Inc. Common Stock | $6.06M | — | $3.39 | ▲ 6.94% | $1.5$38.16 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →Acquired
0
Disposed
80.6K
- Quang X. Pham · June 29, 2026 · Sale7.4K @ $3.03
- Quang X. Pham · June 26, 2026 · Sale9.0K @ $3.05
- Quang X. Pham · June 25, 2026 · Sale2.1K @ $3
- Quang X. Pham · June 23, 2026 · Sale2.3K @ $3.2
- Quang X. Pham · June 22, 2026 · Sale9.2K @ $3.55
- Quang X. Pham · June 17, 2026 · Sale513 @ $3.16
- Quang X. Pham · June 16, 2026 · Sale3.6K @ $3.18
- Quang X. Pham · June 15, 2026 · Sale3.7K @ $3.58
- Quang X. Pham · June 12, 2026 · Sale13.0K @ $3.94
- Quang X. Pham · June 11, 2026 · Sale1.5K @ $4.12
- Quang X. Pham · June 10, 2026 · Sale3.5K @ $4.21
- Quang X. Pham · June 9, 2026 · Sale13.0K @ $4.06
- Quang X. Pham · June 8, 2026 · Sale5.9K @ $4.38
- Quang X. Pham · June 5, 2026 · Sale2.1K @ $4.42
- Quang X. Pham · June 4, 2026 · Sale3.9K @ $4.41
Institutional Ownership
March 31, 2026
- Total shares held
- 75.1K
- Total value held
- $377.0K
- Institutional holders
- 15
Top holders this quarter
- Unknown45.2K
- Unknown21.6K
- Unknown5.5K
- Unknown1.5K
- Unknown393
- Unknown300
- Unknown200
- Unknown150
- Unknown100
- Unknown99
See the full, filterable feed with live charts on the MarketWall dashboard.